Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study-Reference-Cited by-同舟云学术

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

Published:2023-01 Issue:1 Volume:5 Page:e36-e46
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Bjørlykke Kristin H,Ørbo Hilde S,Tveter Anne T,Jyssum Ingrid,Sexton Joseph,Tran Trung T,Christensen Ingrid E,Kro Grete Birkeland,Kvien Tore K,Jahnsen Jørgen,Munthe Ludvig A,Chopra Adity,Warren David J,Mjaaland Siri,Haavardsholm Espen A,Grødeland Gunnveig,Provan Sella A,Vaage John T,Syversen Silje Watterdal,Goll Guro Løvik,Jørgensen Kristin Kaasen

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference39 articles.

1. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review;Parker;Lancet Glob Health,2022

2. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study;Wieske;Lancet Rheumatol,2022

3. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study;Jyssum;Lancet Rheumatol,2022

4. Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease;Haberman;Lancet Rheumatol,2022

5. Immunogenicity and safety of standard and third-dose SARS-CoV-2 vaccination in patients receiving immunosuppressive therapy;Syversen;arthritis Rheumatol,2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study;eBioMedicine;2024-10

2. The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review;Preventive Medicine Reports;2024-08

3. Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study;American Journal of Transplantation;2024-08

4. Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study;Nature Communications;2024-07-23

5. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA);Microbiology Spectrum;2024-04-02